# Glaser Obesity Study

> **NCT00209482** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Glaser Pediatric Research Network** · enrollment: 76 (—)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** glucophage XR

## Key facts

- **NCT ID:** NCT00209482
- **Lead sponsor:** Glaser Pediatric Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 76 (—)
- **Last updated:** 2006-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209482, "Glaser Obesity Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00209482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*